Journal of Behavioral Health and Psychology. 2012; 1(1):(8-318)


Role of piracetam in treatment of cerebral palsy disease

Marwa O. Elgendy, Sadia A. Tayel, Mohamed E.A. Abdelrahim, Ahmed M.A. Ali, Mohamed H. Meabed

Abstract

The term cerebral palsy (CP) refers to neurological disorders that appear in infancy or early childhood and permanently affect body movement and muscle coordination. Piracetam is a compound chemically related to gamma-aminobutyric acid (GABA). It crosses the blood-brain barrier but does not produce any overt central or autonomic nervous system effects. The aim of this prospective study was to evaluate and compare the effect of different doses of Piracetam on clinical status and intellectual power of cerebral palsy patient. The study was carried out on 40 cerebral palsy patients; 22 out of them were females, aged from 1 to 4.75 years old; from outpatient clinic at Beni Suef University Hospital. Patients were divided into four equal groups. Group A received dose 40mg/kg/day, group B received dose 80mg/kg/day, group C received dose 120mg/kg/day and group D was the control group, did not receive any Piracetam. Patients were treated and followed up for 6 month. They were represented by full history taking and clinical examination. The Intelligence quotient (IQ) test was done for every patient to evaluate mental development before starting piracetam treatment and every month for six months. There was an improvement in general health of children after therapy and quotient. Dose 120mg/kg/day of piracetam was found to be the most effective dose piracetam in the treatment of cerebral palsy disease as shown by improved scores of IQ test. The best improvement in mental and motor development was greatly observed in group C. Dose 40mg/kg/day of piracetam showed insignificant effect on improving the IQ of the patients

Most Viewed Article
  • Using Social Media Engagement to Raise Pre-Diabetes Awareness for Rural Idaho Hispanics or Latinos
    Tanna M. Woods PhD MSN RN, Heidi K. Lewis DNP RN and Mary A. Nies PhD RN FAAN FAAHB
    » Abstract » doi: 10.5455/jbh.XXXXXX

  • Evaluating the Gap of Integrated Behavioral Health Programs for NCDs in China, Vietnam, Cambodia, and Thailand
    Ronald R. O’Donnell, Jennifer Rolfes, Shiyou Wu, Mohamed Abdalla, Flavio F. Marsiglia, Pristine Mei, Pham Le An, Puchong Senanuch, Patraporn Tungpunkom, Virya Koy, Hong Tao, Kim Savuon and Rodger Kessler
    » Abstract » doi: 10.33425/2832-4579/21038

  • Occupational Therapy Assessment and Intervention of a 22 Month Old Girl with Feeding Refusal
    Berta Gándara-Gafo PhD, Tania Moriyón-Iglesias MSc and Isabelle Beaudry-Bellefeuille PhD
    » Abstract » doi: 10.33425/2832-4579/21037

  • Biological sex and Covid-19: Science versus ideology
    Carole Jahme and Ulrich Kutschera
    » Abstract » doi: 10.33425/2832-4579/21036

  • A case of chronic schizophrenia with emergent dementia: Successful medication reduction and its explication
    Grace E Jackson and Matthew Tunzi
    » Abstract » doi: 10.33425/2832-4579/21035

Most Downloaded
  • Using Social Media Engagement to Raise Pre-Diabetes Awareness for Rural Idaho Hispanics or Latinos
    Tanna M. Woods PhD MSN RN, Heidi K. Lewis DNP RN and Mary A. Nies PhD RN FAAN FAAHB
    » Abstract » doi: 10.5455/jbh.XXXXXX

  • Evaluating the Gap of Integrated Behavioral Health Programs for NCDs in China, Vietnam, Cambodia, and Thailand
    Ronald R. O’Donnell, Jennifer Rolfes, Shiyou Wu, Mohamed Abdalla, Flavio F. Marsiglia, Pristine Mei, Pham Le An, Puchong Senanuch, Patraporn Tungpunkom, Virya Koy, Hong Tao, Kim Savuon and Rodger Kessler
    » Abstract » doi: 10.33425/2832-4579/21038

  • Occupational Therapy Assessment and Intervention of a 22 Month Old Girl with Feeding Refusal
    Berta Gándara-Gafo PhD, Tania Moriyón-Iglesias MSc and Isabelle Beaudry-Bellefeuille PhD
    » Abstract » doi: 10.33425/2832-4579/21037

  • Biological sex and Covid-19: Science versus ideology
    Carole Jahme and Ulrich Kutschera
    » Abstract » doi: 10.33425/2832-4579/21036

  • A case of chronic schizophrenia with emergent dementia: Successful medication reduction and its explication
    Grace E Jackson and Matthew Tunzi
    » Abstract » doi: 10.33425/2832-4579/21035